A massive fire is burning in Delaware County, Pennsylvania, Wednesday, sending a huge plume of dark black smoke into the sky.

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Evaluation of concomitant medications in advanced prostate cancer patients receiving apalutamide: TITAN and SPARTAN post-hoc analysis. The data cutoff date was January 31, 2023. † Time to testosterone ...

Softball fans heading to the NCAA Women’s College World Series in Oklahoma City will once again have a public transit option to avoid gameday traffic and parking concerns. EMBARK announced it will ...

Arc Raiders and The Finals developer Embark Studios has announced the departure of co-founder and CCO Rob Runesson after he faced allegations of sexual misconduct towards a female streamer who ...

Embark Studios, the dev behind Arc Raiders and The Finals has "mutually agreed to part ways" with co-founder and CCO Rob Runesson following public allegations that he engaged in sexual misconduct with ...

Arc Raiders and The Finals dev Embark Studios has "mutually agreed to part ways" with co-founder and CCO Rob Runesson after allegations of sexual misconduct. In a statement via IGN, the ...

For the quickest way to join, simply enter your email below and get access. We will send a confirmation and sign you up to our newsletter to keep you updated on all your gaming news.

Enzalutamide/leuprolide reduced metastasis or death vs leuprolide alone (HR, 0.42) and improved overall survival (HR, 0.597); enzalutamide monotherapy also improved ...

One is less expensive, while the other provides more legal protections. Here’s how to decide. Greg Daugherty has worked 25+ years as an editor and writer for major publications and websites. He is ...

Metastatic lesion location and avidity on baseline PSMA PET/CT as predictor of duration of Lu177 treatment in men with metastatic castrate resistant prostate cancer. Data cutoff: January 31, 2023. The ...